Artivion | CRY - Коммерческие и административные расходы





Коммерческие и административные расходы Изменить Дата
Abbott USD 4.27B 669M 2026-09
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.88M 319K 2026-09
Baxter International USD 730M 5M 2026-09
Becton, Dickinson and Co. USD 1.26B 1000K 2026-09
Boston Scientific USD 1.68B 120M 2026-09
Edwards Lifesciences USD 560.9M 300K 2026-09
Inogen USD 43.77M 510K 2024-06
Integra LifeSciences USD 161.02M 5.2M 2026-09
J&J USD 6.25B 168M 2026-09
Mesa Laboratories USD 27.31M 380K 2024-09
Orthofix International USD 130.35M 11.31M 2025-12
Pfizer USD 3.28B 132M 2026-09
ResMed USD 290.65M 10.86M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 113.94M 2.3M 2026-09
Teleflex USD 220.72M 7.21M 2026-09
Terumo JPY 109.58B 120M 2026-09
Trinity Biotech USD 4.71M 1.08M 2026-03